Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) CEO Compensation Is Looking A Bit Stretched At The Moment
Aug 06
Have your own idea? Try our Stock Screener
Indian (NIFTY) Pharma Industry Analysis
UpdatedAug 13, 2025
DataAggregated Company Financials
Companies172
- 7D-1.1%
- 3M1.8%
- 1Y-1.8%
- YTD-7.4%
Over the last 7 days, the Pharma industry has dropped 1.1%, driven by Mankind Pharma declining 3.5%. As for the longer term, the industry's performance has been flat for the past year. As for the next few years, earnings are expected to grow by 15% per annum.
Industry Valuation and Performance
Has the Indian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 13 Aug 2025 | ₹20.0t | ₹4.1t | ₹592.4b | 31.2x | 33.8x | 4.9x |
| Fri, 11 Jul 2025 | ₹20.4t | ₹4.0t | ₹594.1b | 32.6x | 34.3x | 5.1x |
| Sun, 08 Jun 2025 | ₹20.2t | ₹4.0t | ₹595.3b | 32x | 33.9x | 5.1x |
| Tue, 06 May 2025 | ₹19.7t | ₹3.9t | ₹563.0b | 29.8x | 35x | 5.1x |
| Thu, 03 Apr 2025 | ₹19.2t | ₹3.9t | ₹559.4b | 29.5x | 34.4x | 4.9x |
| Sat, 01 Mar 2025 | ₹18.0t | ₹3.9t | ₹561.5b | 25.8x | 32.1x | 4.6x |
| Mon, 27 Jan 2025 | ₹19.9t | ₹3.8t | ₹531.6b | 31.6x | 37.5x | 5.2x |
| Wed, 25 Dec 2024 | ₹20.8t | ₹3.8t | ₹526.7b | 34.8x | 39.4x | 5.5x |
| Fri, 22 Nov 2024 | ₹20.1t | ₹3.8t | ₹526.7b | 31.6x | 38.1x | 5.3x |
| Sun, 20 Oct 2024 | ₹21.4t | ₹3.7t | ₹492.6b | 40.1x | 43.4x | 5.7x |
| Tue, 17 Sep 2024 | ₹21.7t | ₹3.7t | ₹492.6b | 42.6x | 44.1x | 5.8x |
| Thu, 15 Aug 2024 | ₹20.2t | ₹3.8t | ₹489.0b | 35x | 41.4x | 5.4x |
| Sat, 13 Jul 2024 | ₹18.6t | ₹3.6t | ₹449.9b | 35x | 41.4x | 5.2x |
| Mon, 10 Jun 2024 | ₹17.4t | ₹3.6t | ₹448.1b | 32.7x | 38.8x | 4.9x |
| Wed, 08 May 2024 | ₹16.9t | ₹3.5t | ₹420.1b | 34.3x | 40.1x | 4.8x |
| Fri, 05 Apr 2024 | ₹17.1t | ₹3.5t | ₹418.9b | 33.5x | 40.9x | 4.9x |
| Sun, 03 Mar 2024 | ₹16.9t | ₹3.5t | ₹418.7b | 33.2x | 40.4x | 4.9x |
| Tue, 30 Jan 2024 | ₹15.9t | ₹3.4t | ₹396.1b | 34.8x | 40.2x | 4.7x |
| Thu, 28 Dec 2023 | ₹14.8t | ₹3.4t | ₹395.2b | 32.8x | 37.5x | 4.4x |
| Sat, 25 Nov 2023 | ₹14.0t | ₹3.4t | ₹395.1b | 31x | 35.6x | 4.2x |
| Mon, 23 Oct 2023 | ₹13.1t | ₹3.3t | ₹368.0b | 29.8x | 35.6x | 4x |
| Wed, 20 Sep 2023 | ₹13.3t | ₹3.3t | ₹369.5b | 30.3x | 35.9x | 4.1x |
| Fri, 18 Aug 2023 | ₹13.1t | ₹3.3t | ₹367.0b | 28.7x | 35.6x | 4x |
| Sun, 16 Jul 2023 | ₹11.9t | ₹3.2t | ₹342.6b | 26.3x | 34.9x | 3.8x |
| Tue, 13 Jun 2023 | ₹11.0t | ₹3.2t | ₹342.4b | 25.8x | 32.1x | 3.5x |
| Thu, 11 May 2023 | ₹10.6t | ₹3.1t | ₹297.8b | 27.2x | 35.5x | 3.4x |
| Sat, 08 Apr 2023 | ₹9.8t | ₹3.0t | ₹277.5b | 24.5x | 35.2x | 3.3x |
| Mon, 06 Mar 2023 | ₹9.4t | ₹3.0t | ₹277.5b | 23x | 33.9x | 3.1x |
| Wed, 01 Feb 2023 | ₹9.7t | ₹2.9t | ₹284.5b | 25.5x | 34.1x | 3.3x |
| Fri, 30 Dec 2022 | ₹9.9t | ₹2.9t | ₹274.9b | 26.7x | 36x | 3.5x |
| Sun, 27 Nov 2022 | ₹10.1t | ₹2.9t | ₹274.9b | 26.9x | 36.8x | 3.5x |
| Tue, 25 Oct 2022 | ₹10.1t | ₹2.8t | ₹259.9b | 23.9x | 38.9x | 3.6x |
| Thu, 22 Sep 2022 | ₹9.7t | ₹2.8t | ₹261.9b | 23.4x | 36.9x | 3.5x |
| Sat, 20 Aug 2022 | ₹9.8t | ₹2.8t | ₹261.9b | 22.3x | 37.3x | 3.5x |
Price to Earnings Ratio
37.3x
Current Industry PE
- Investors are pessimistic on the Indian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 33.8x which is lower than its 3-year average PE of 37.1x.
- The 3-year average PS ratio of 4.4x is lower than the industry's current PS ratio of 4.9x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 31% per year over the last three years.
- Revenues for these companies have grown 13% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | -1.14% | |
| Healthcare | -1.07% | |
| Pharma | -1.09% | |
| Pharma | -1.09% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries | ₹1.64k | 2.8% +₹107.0b | -5.8% | PE37.9x | |
| 500257 Lupin | ₹1.99k | 7.4% +₹62.8b | -4.1% | PE24.6x | |
| ALKEM Alkem Laboratories | ₹5.39k | 10.6% +₹61.9b | -5.2% | PE28.2x | |
| CIPLA Cipla | ₹1.56k | 5.0% +₹60.0b | -0.2% | PE23.4x | |
| ZYDUSLIFE Zydus Lifesciences | ₹988.60 | 6.0% +₹56.2b | -15.5% | PE21.8x |
